IngentaConnect Evaluation of serum transferrin receptor assay in a centralized i...

Authors: O'BROIN, S.; KELLEHER, B.; BALFE, A.; Mc MAHON, C.

Source: Clinical & Laboratory Haematology, Volume 27, Number 3, June 2005 , pp. 190-194(5)

Abstract:

Summary

This study assesses the impact of permitting unrestricted access to requests for soluble transferrin receptor (sTfR) analysis in screening for iron deficiency (ID). Biochemical data including sTfR, serum ferritin (sFn), transferrin saturation, zinc protoporphyrins (ZPP) and also erythrocyte indices are used to highlight the differences between hospital (H) and general practitioner (GP) patient groups. A significantly higher number of abnormal sFn values (40%) over abnormal sTfR values (25%) occurred in GP patients. This trend was reversed in the H patient group where high sTfR values predominated. Consequently, screening with sFn, exclusively, missed ID (sTfR > 28.1 nmol/l) in 5% of GP patients and in 20% of H patients. Some 40% of H patients had elevated CRP values (CRP > 10 mg/l) indicating inflammatory disease, however, ZPP was more efficient than CRP at screening the validity of normal sFn values in the group. Unrestricted access to sTfR, sFn and ZPP analyses should expedite diagnosis in all patients, particularly H patients, but may be costly. The high specificity (>90%) of the mean cell haemoglobin for ID may be under-utilized diagnostically.

Keywords: Iron deficiency; serum ferritin; transferrin receptor; zinc protoporphyrin; full blood count; C-reactive protein

Document Type: Research article

DOI: 10.1111/j.1365-2257.2005.00680.x

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax Refund Policy

Evaluation of serum transferrin receptor assay in a centralized iron screening service